197 related articles for article (PubMed ID: 18560420)
21. Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway.
Nakanishi T; Hayashi A; Kunisawa J; Tsutsumi Y; Tanaka K; Yashiro-Ohtani Y; Nakanishi M; Fujiwara H; Hamaoka T; Mayumi T
Eur J Immunol; 2000 Jun; 30(6):1740-7. PubMed ID: 10898512
[TBL] [Abstract][Full Text] [Related]
22. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
23. Intracellular processing of hapten-modified protein for MHC class I presentation: cytoplasmic delivery by pH-sensitive liposomes.
Martin S; Niedermann G; Leipner C; Eichmann K; Weltzien HU
Immunol Lett; 1993 Aug; 37(2-3):97-102. PubMed ID: 8258464
[TBL] [Abstract][Full Text] [Related]
24. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.
Shen H; Ackerman AL; Cody V; Giodini A; Hinson ER; Cresswell P; Edelson RL; Saltzman WM; Hanlon DJ
Immunology; 2006 Jan; 117(1):78-88. PubMed ID: 16423043
[TBL] [Abstract][Full Text] [Related]
25. Effects of lipofectin-antigen complexes on major histocompatibility complex class I-restricted antigen presentation pathway in murine dendritic cells and on dendritic cell maturation.
Okada N; Saito T; Mori K; Masunaga Y; Fujii Y; Fujita J; Fujimoto K; Nakanishi T; Tanaka K; Nakagawa S; Mayumi T; Fujita T; Yamamoto A
Biochim Biophys Acta; 2001 Aug; 1527(3):97-101. PubMed ID: 11479025
[TBL] [Abstract][Full Text] [Related]
26. Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells.
Tardif V; Riquelme SA; Remy S; Carreño LJ; Cortés CM; Simon T; Hill M; Louvet C; Riedel CA; Blancou P; Bach JM; Chauveau C; Bueno SM; Anegon I; Kalergis AM
Eur J Immunol; 2013 Nov; 43(11):2832-44. PubMed ID: 23852701
[TBL] [Abstract][Full Text] [Related]
27. The Improved Antigen Uptake and Presentation of Dendritic Cells Using Cell-Penetrating D-octaarginine-Linked PNVA-co-AA as a Novel Dendritic Cell-Based Vaccine.
Fujioka Y; Ueki H; A R; Sasajima A; Tomono T; Ukawa M; Yagi H; Sakuma S; Kitagawa K; Shirakawa T
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892182
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic analysis of the tissue distribution of octaarginine modified liposomes in mice.
Mudhakir D; Akita H; Khalil IA; Futaki S; Harashima H
Drug Metab Pharmacokinet; 2005 Aug; 20(4):275-81. PubMed ID: 16141607
[TBL] [Abstract][Full Text] [Related]
29. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
[TBL] [Abstract][Full Text] [Related]
30. Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells.
Lee YH; Lee YR; Kim KH; Im SA; Song S; Lee MK; Kim Y; Hong JT; Kim K; Lee CK
Int Immunopharmacol; 2011 Aug; 11(8):985-91. PubMed ID: 21354357
[TBL] [Abstract][Full Text] [Related]
31. Efficient scavenger receptor-mediated uptake and cross-presentation of negatively charged soluble antigens by dendritic cells.
Shakushiro K; Yamasaki Y; Nishikawa M; Takakura Y
Immunology; 2004 Jun; 112(2):211-8. PubMed ID: 15147564
[TBL] [Abstract][Full Text] [Related]
32. Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery.
Tang J; Fu H; Kuang Q; Zhang L; Zhang Q; Liu Y; Ran R; Gao H; Zhang Z; He Q
J Drug Target; 2014 May; 22(4):313-26. PubMed ID: 24404866
[TBL] [Abstract][Full Text] [Related]
33. Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides.
Laus R; Graddis TJ; Hakim I; Vidovic D
Nat Biotechnol; 2000 Dec; 18(12):1269-72. PubMed ID: 11101805
[TBL] [Abstract][Full Text] [Related]
34. Virosome-mediated delivery of protein antigens to dendritic cells.
Bungener L; Serre K; Bijl L; Leserman L; Wilschut J; Daemen T; Machy P
Vaccine; 2002 May; 20(17-18):2287-95. PubMed ID: 12009284
[TBL] [Abstract][Full Text] [Related]
35. Differential use of autophagy by primary dendritic cells specialized in cross-presentation.
Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA
Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899
[TBL] [Abstract][Full Text] [Related]
36. Photochemical targeting of antigens to the cytosol for stimulation of MHC class-I-restricted T-cell responses.
Waeckerle-Men Y; Mauracher A; Håkerud M; Mohanan D; Kündig TM; Høgset A; Johansen P
Eur J Pharm Biopharm; 2013 Sep; 85(1):34-41. PubMed ID: 23461859
[TBL] [Abstract][Full Text] [Related]
37. [Development of effective antigen delivery carrier to dendritic cells via Fc receptor in cancer immunotherapy].
Suzuki R; Utoguchi N; Kawamura K; Kadowaki N; Okada N; Takizawa T; Uchiyama T; Maruyama K
Yakugaku Zasshi; 2007 Feb; 127(2):301-6. PubMed ID: 17268150
[TBL] [Abstract][Full Text] [Related]
38. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
40. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation.
Harding CV; Collins DS; Kanagawa O; Unanue ER
J Immunol; 1991 Nov; 147(9):2860-3. PubMed ID: 1918996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
